Author: Lauren Neergaard
-
FDA restricts J&J’s COVID-19 vaccine due to blood clot risk
—
by
WASHINGTON • U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for…
-
FDA panel endorses lower-dose Moderna COVID shot for booster
—
by
WASHINGTON • The panel of outside advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, as well as younger adults with other health problems, jobs or living situations that put them at increased risk from COVID-19. The recommendation is nonbinding but it’s a key step toward expanding the…
-
COVID-19 boosters are coming but who will get them and when?
—
by
NEW YORK • COVID-19 booster shots might be coming for at least some Americans but already the Biden administration is being forced to scale back expectations — illustrating just how much important science still has to be worked out. The initial plan was to offer Pfizer or Moderna boosters starting Sept. 20, contingent on authorization…
-
Pfizer says its COVID-19 vaccine protects younger teens
—
by
NEW YORK • Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in the fall. Most COVID-19 vaccines being rolled out worldwide are for adults, who are at higher risk…
-
U.S. vaccinations ramp up as 2nd COVID-19 shot nears
—
by
WASHINGTON • Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization. A day after the rollout of Pfizer-BioNTech’s coronavirus shots, the Food and Drug Administration said its preliminary analysis confirmed…
-
Britain OKs Pfizer vaccine and will begin shots within days
—
by
LONDON • Britain became the first country in the world to authorize a rigorously tested COVID-19 vaccine Wednesday and could be dispensing shots within days — a historic step toward eventually ending the outbreak that has killed more than 1.4 million people around the globe. In giving the go-ahead for emergency use of the vaccine…
-
U.S. experts vow ‘no cutting corners’ as vaccine tests expand
—
by
WASHINGTON • A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves. Hopes are high that answers about at least one of…
-
Fauci: U.S. ‘going in wrong direction’ in coronavirus outbreak
—
by
WASHINGTON • The U.S. is “going in the wrong direction” with the coronavirus surging badly enough that Dr. Anthony Fauci told senators Tuesday some regions are putting the country at risk — just as schools and colleges are wrestling with how to safely reopen. With about 40,000 new cases being reported a day, Fauci, the…
-
Dr. Fauci hopeful for a vaccine by late 2020, early 2021
—
by
WASHINGTON • Dr. Anthony Fauci said Tuesday that he is cautiously optimistic there will be a COVID-19 vaccine by the end of the year or early 2021, but warned that the next few weeks will be critical to tamping down coronavirus hot spots around the country. Fauci and other top health officials also said they…
-
Fauci tells Congress U.S. coronavirus outbreak not yet under control
—
by
WASHINGTON • The U.S. government’s top infectious disease expert issued a blunt warning Tuesday that cities and states could “turn back the clock” and see more COVID-19 deaths and economic damage alike if they lift coronavirus stay-at-home orders too fast — a sharp contrast as President Donald Trump pushes to right a free-falling economy. “There…